KZA 0.00% 8.0¢ kazia therapeutics limited

''Biotech, domestic healthcare manufacturing and food staples...

  1. 21,297 Posts.
    lightbulb Created with Sketch. 881
    ''Biotech, domestic healthcare manufacturing and food staples will still have export demand and so the market will naturally favour these. ''

    Are you serious Kickst@rter

    Do you honestly think the market will favour pre revenue - highly speculative biotechs in phase 11 as safe havens

    Biotechs with revenues and actual commercialised drugs - like the big billion dollar pharmas

    DYOR

 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.